Get Our FREE Newsletter

Sign Up

Biotech Stocks Have Colds, but They Can Heal

Spread the love

This year hasn’t been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to pursue lower drug prices. As a result, the ALPS Medical Breakthroughs ETF (SBIO) lost 1.81% on the week, but that performance could be an overreaction indicating […] Read more at ETFtrends.com.

This post was originally published on this site